Capsule · The news app for modern leaders

Trends and Insights

15 Jan 2024

FDA Clears Menstrual Blood Testing for Diabetes Monitoring

US company [Qvin]( has received FDA clearance for its [groundbreaking Q-Pad™ and A1c Test](, revolutionizing healthcare for women, particularly those with diabetes. This innovative product uses menstrual blood for testing, offering a non-invasive, convenient alternative to traditional blood draws. It enables at-home collection and analysis of key biomarkers, including blood sugar levels. The Q-Pad, developed with contributions from Stanford University researchers, also shows potential in diagnosing conditions like anemia, fertility issues, and HPV, making healthcare more accessible and cost-effective.

an image representing an item